Market overreaction offers an opportunity to invest in an E&C leader.
As part of an ongoing divestment program, the wide-moat firm sold some healthcare diagnostic and monitoring assets to Veritas Capital.
The proposed tie-up of Praxair and Linde will result in a clear market leader.
The no-moat engineering firm is still undervalued as we reduce our fair value estimate.
A favorable Delaware Supreme Court ruling in favor of the firm lifted its stock yesterday, but shares remain undervalued.
We expect his plan to include reducing risk and improving execution.
The firm is making steady headway in certain high-value sectors and continues to commercialize new printers, materials, and related products.
Our revised fair value estimate reflects an improving product mix, expense control, and cash flow balanced by continued weakness in the market for 3-D printing products and services.
The firm is making steady headway in certain high-value sectors, including the broader healthcare vertical and in direct metal parts printing.
Shares of Versum began trading this month, allowing investors an opportunity to benefit from a newly independent, high-quality business.
Despite generally rich valuations across the industrials space, some pockets of value still exist.